Skip to content
Delayed ~15 min

EVH EVOLENT HEALTH CLASS A

Consumer Discretionary · Russell 2000

Next earnings: not announced yet

What 17 analyst firms say about EVOLENT HEALTH CLASS A: their latest ratings, price targets and how far the stock is from them. How it works

4.58 USD+0.04 (+0.88%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+27.9%to the avg target 5.86 USD+1.28 USD
Buy 12 · Hold 4 · Sell 0

16 rated views · 17 analyst/firm records · 17 firms

Latest report18 Aug 2026avg report date 1 Jun
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
  • Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD

Recent analyst activity · last 90 days

Our tracked history has 9 reports on EVH from 8 analyst firms in the last 90 days (17 firms in the past year).

Comparing each firm's latest target with its previous one: 1 raised its price target, 2 lowered it, 2 left it unchanged and 1 has its first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Needham raised its target from $5.00 (set 7 May 2026) to $6.00 on 5 Nov 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BMO Capital MarketsSean W DodgeBuy7 Aug 20266.00 USD
BTIGDavid M LarsenBuy16 Jul 20268.00 USD
Canaccord GenuityRichard CloseBuy10 Aug 20266.00 USD
CitigroupDaniel GrosslightBuy10 Aug 20266.00 USD
Citizens JMPConstantine Kyriakos DavidesBuy27 Feb 20266.00 USD
JPMorganJohn StanselBuy18 Aug 20266.00 USD
KeyBanc Capital MarketsMatthew GillmorHold9 Aug 2026—
NeedhamMatthew SheaBuy7 May 20265.00 USD
OppenheimerMichael WiederhornBuy2 Mar 20266.00 USD
Piper SandlerJessica E TassanBuy15 Jul 20266.00 USD
RBC Capital MarketsRyan HalstedHold8 May 20263.00 USD
StephensJeff GarroBuy13 Nov 20257.00 USD
TD CowenCharles RhyeeBuy17 Aug 20266.00 USD
TruistJailendra SinghHold12 Aug 20266.00 USD
UBSKevin CaliendoBuy26 Feb 20265.00 USD
Weiss RatingsUnnamed analyst—16 Oct 2026—
Data feed RESEARCHResearch TeamHold22 May 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 07:01 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.